Aequus Pharmaceuticals Inc AQS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 0.02
- Day Range
- CAD 0.02–0.02
- 52-Week Range
- CAD 0.01–0.06
- Bid/Ask
- CAD 0.01 / CAD 0.02
- Market Cap
- CAD 1.99 Mil
- Volume/Avg
- 15,000 / 117,894
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.39
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 14
- Website
- https://www.aequuspharma.ca
Valuation
|
Metric
|
AQS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 3.39 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AQS
|
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.12 |
Interest Coverage | −24.34 |
Quick Ratio
AQS
Profitability
|
Metric
|
AQS
|
|---|---|
Return on Assets (Normalized) | −146.80% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −177.31% |
Return on Assets
AQS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Jqmybtvbr | Dkr | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Rzrjfdvh | Kmjmyz | $68.1 Bil | |
HLN
| Haleon PLC ADR | Rjgnvkqp | Qcl | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zhbrylpj | Kxcr | $14.3 Bil | |
VTRS
| Viatris Inc | Hldgwvdf | Wfpb | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kzrfyslm | Gryv | $11.9 Bil | |
CTLT
| Catalent Inc | Yhqmldhw | Mncqsb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rlbrczvr | Zmcqg | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Xyglfdvm | Mnjn | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Skhyycst | Mmnwps | $3.4 Bil |